Drugs / SoftOx Biofilm Eradicator
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05710094 | Oct 2021 → Aug 2022 | ulcer of lower limbs | SoftOx Solutions AS | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2024-06-02 | SoftOx Solutions AS | Results SoftOx Biofilm Eradicator (SBE) study is published soft-ox.com ↗
It shows SBE is safe and tolerable in humans. |
| 2022-12-15 | SoftOx Solutions AS | Results SOFTOX SOLUTIONS AS: FINAL REPORT REAFFIRMS POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR soft-ox.com ↗
The final report reaffirms previous findings that SBE is safe and well-tolerated by patients suffering from chronic leg wounds. |
| 2022-10-04 | SoftOx Solutions AS | Results SOFTOX SOLUTIONS AS: POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR - UPDATE ON THE COMPANY’S FINANCIAL SITUATION soft-ox.com ↗
The SoftOx Biofilm Eradicator (SBE) was shown to be safe and well tolerated. |
All press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-06-02 | SoftOx Solutions AS | SoftOx Biofilm Eradicator (SBE) study is published soft-ox.com ↗ |
| 2022-12-15 | SoftOx Solutions AS | SOFTOX SOLUTIONS AS: FINAL REPORT REAFFIRMS POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR soft-ox.com ↗ |
| 2022-10-04 | SoftOx Solutions AS | SOFTOX SOLUTIONS AS: POSITIVE TOP LINE PHASE 1 RESULTS FOR SOFTOX BIOFILM ERADICATOR - UPDATE ON THE COMPANY’S FINANCIAL SITUATION soft-ox.com ↗ |
| 2022-01-24 | SoftOx Solutions AS | SoftOx Solutions AS: SOFTOX BIOFILM ERADICATOR STUDY (SBE-01) ADVANCES TO NEXT DOSE LEVEL DUE TO EXCELLENT SAFETY IN THE TREATMENT OF CHRONIC WOUNDS soft-ox.com ↗ |
| 2021-07-19 | SoftOx Solutions AS | SoftOx Solutions AS - Project update: SoftOx Biofilm Eradicator (SBE) soft-ox.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SoftOx Biofilm Eradicator | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05710094 ↗ |
| Route | Topical | “topically applied SoftOx Biofilm Eradicator (SBE)” NCT05710094 ↗ |